507 related articles for article (PubMed ID: 31315489)
1. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
Du Y; Li X; Su C; Wang L; Jiang J; Hong B
Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
[No Abstract] [Full Text] [Related]
2. Gut microbiota: a promising target against cardiometabolic diseases.
Warmbrunn MV; Herrema H; Aron-Wisnewsky J; Soeters MR; Van Raalte DH; Nieuwdorp M
Expert Rev Endocrinol Metab; 2020 Jan; 15(1):13-27. PubMed ID: 32066294
[No Abstract] [Full Text] [Related]
3. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
4. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
Wijdeveld M; Nieuwdorp M; IJzerman R
Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
[TBL] [Abstract][Full Text] [Related]
5. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
Tang WH; Hazen SL
Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
7. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
Schiattarella GG; Sannino A; Esposito G; Perrino C
Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome as a novel cardiovascular therapeutic target.
Singh V; Yeoh BS; Vijay-Kumar M
Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
[TBL] [Abstract][Full Text] [Related]
10. Sequence meets function-microbiota and cardiovascular disease.
Kim M; Huda MN; Bennett BJ
Cardiovasc Res; 2022 Jan; 118(2):399-412. PubMed ID: 33537709
[TBL] [Abstract][Full Text] [Related]
11. Role of the Gut Microbiome in Diabetes and Cardiovascular Diseases Including Restoration and Targeting Approaches- A Review.
Alka Ahuja ; Saraswathy Mp ; Nandakumar S ; Prakash F A; Kn G; Um D
Drug Metab Bioanal Lett; 2022; 15(3):133-149. PubMed ID: 36508273
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Heart, Vascular Injury.
Zeng C; Tan H
Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
[TBL] [Abstract][Full Text] [Related]
13. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
Chambers ES; Preston T; Frost G; Morrison DJ
Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
[TBL] [Abstract][Full Text] [Related]
14. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.
Lewis CV; Taylor WR
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1227-H1233. PubMed ID: 32986965
[TBL] [Abstract][Full Text] [Related]
15. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.
Sanchez-Rodriguez E; Egea-Zorrilla A; Plaza-Díaz J; Aragón-Vela J; Muñoz-Quezada S; Tercedor-Sánchez L; Abadia-Molina F
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110880
[TBL] [Abstract][Full Text] [Related]
16. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases.
McGrail L; Garelnabi M
Curr Pharm Biotechnol; 2020; 21(7):578-586. PubMed ID: 31713494
[TBL] [Abstract][Full Text] [Related]
17. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
Koopen AM; Groen AK; Nieuwdorp M
Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases.
Yamashita T; Kasahara K; Emoto T; Matsumoto T; Mizoguchi T; Kitano N; Sasaki N; Hirata K
Circ J; 2015; 79(9):1882-90. PubMed ID: 26212124
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota in Vascular Disease: Therapeutic Target?
Anbazhagan AN; Priyamvada S; Priyadarshini M
Curr Vasc Pharmacol; 2017; 15(4):291-295. PubMed ID: 28056754
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
